DPP-4 inhibitors

Possible adverse effects of dpp 4 inhibitors in type 2 diabetes

Possible adverse effects of dpp 4 inhibitors in type 2 diabetes

What are incretins and incretinomimetics, which drugs from the group of dipeptidyl peptidase 4 inhibitors and glucagon-like peptide 1 agonists are used in the treatment of diabetes? Today you will learn what these long and complex words mean, and most importantly, how to apply this knowledge. This article will focus on completely new drugs-analogs of …

Possible adverse effects of dpp 4 inhibitors in type 2 diabetes Read More »

No difference between TZDs and DPP-4 inhibitors or sulphonylureas added to metformin in type 2 diabetes

No difference between TZDs and DPP-4 inhibitors or sulphonylureas added to metformin in type 2 diabetes

Research question: In people with type 2 diabetes inadequately controlled with metformin, which additional oral therapy offers the greatest improvement in HbA1c? The reviewers just looked at glycaemic control in patients whose starting HbA1c was 7% or higher at 12 weeks or longer follow-up. The evidence: Eight randomised trials were found, which looked at various …

No difference between TZDs and DPP-4 inhibitors or sulphonylureas added to metformin in type 2 diabetes Read More »